A key component of drug courts is regular status hearings in which the judge reviews client progress and imposes sanctions or rewards for infractions or achievements; however, little is known about whether drug court clients fully understand the reasons for judicial responses and make clear connections between their behavior and judicially imposed consequences. Thus, we hypothesized that providing graphic performance feedback would improve clients' perceptions of procedural justice and increase the likelihood of success. This study examines the feasibility, acceptability, and preliminary efficacy of a visual performance feedback (VPF) procedure designed to improve judge-client communication during status hearings. Seventy-five adult misdemeanor drug court participants were randomized to a VPF (n ϭ 37) or status hearings as usual (n ϭ 38) condition. In the VPF condition, the judge projected and described two graphs for each client (i.e., abstinence rates, treatment attendance for the past two months). Outcomes included feasibility, client and stakeholder acceptability, urinalysis-confirmed abstinence, treatment attendance, perceptions of procedural justice, and duration of client-judge interactions. Findings revealed a high level of judge adherence to the VPF (feasibility), client and stakeholder acceptability of the VPF procedure, and significantly longer client-judge interactions in the VPF condition. No significant differences were observed for client-level efficacy outcomes. Overall, this study demonstrated that providing VPF to drug court clients during judicial status hearings is feasible and acceptable. Future fully powered trials of the VPF procedure are needed to further examine its efficacy in improving outcomes for drug court clients.
Nearly 80% of criminal offenders are involved with illicit drugs and alcohol (National Center on Addiction and Substance Abuse, 2011). Drug courts emerged in 1989 as a way to address this intersection of substance use and criminal activity. They are specialized judicial dockets targeting criminal defendants and offenders who have substance use disorders. Individuals who voluntarily enter a drug court program are required to complete a standard regimen of substance abuse treatment, undergo regular random urine drug screening, and attend judicial status hearings in which the judge reviews clients' treatment progress and compliance with drug court requirements and imposes consequences based on their performance (Brown, Zuelsdorff, & Gassman, 2009; Huddleston & Marlowe, 2011 ; National Association of Drug Court Professionals, 1997). Currently, there are more than 3,000 drug courts in the United States and additional courts in 13 other countries (National Drug Court Resource Center, 2016) . Over the past two decades, drug courts have emerged as one of the most effective and empirically supported intervention strategies for reducing drug use and criminal recidivism in offenders (Aos, Phipps, Barnoski, & Lieb, 2001; Belenko, 2001; Brown, 2010; Gottfredson, Kearley, Najaka, & Rocha, 2005; Latimer, Morton-Bourgon, & Chretien, 2006; Lowenkamp, Holsinger, & Latessa, 2005; Rempel et al., 2003; Shaffer, 2006; Turner, Greenwood, Fain, & Deschenes, 1999; Wilson, Mitchell, & MacKenzie, 2006; Wilson & Zozula, 2012) .
Judicial Status Hearings
Regular meetings with the judge (i.e., judicial status hearings) are generally viewed as one of the defining elements of drug court (Marlowe, Festinger, & Lee, 2004) . During these hearings, which are typically scheduled every few weeks or monthly throughout the program, the judge meets with drug court clients to review their ongoing progress in the drug court and to deliver rewards and sanctions in response to client behavior (e.g., treatment or status hearing attendance, urinalysis results, new arrests). The drug court judge has the unique authority to provide swift and certain consequences, which are key elements of effective behavior modification (Harrell & Roman, 2001; Marlowe & Kirby, 1999) . As such, the judge is able to serve as a potent source of differential reinforcement. These interactions may also lead participants to become vested in obtaining the judge's approval.
Another factor that may increase the potency of judicially delivered consequences is the judge's central role as the leader of the drug court team. The judge synthesizes information and recommendations from all stakeholders including the prosecutor, public defender, and treatment provider and, therefore, may be seen as speaking for the entire team when providing differential reinforcement. In fact, better client outcomes result when judges spend at least 3 min speaking with the client during status hearings (Carey, Finigan, & Pukstas, 2008; Carey, Mackin, & Finigan, 2012) . Over a decade of quantitative and qualitative research supports the critical influence of the judge on the success of the court (e.g., Festinger et al., 2002; Marlowe, Festinger, Arabia, Dugosh, Benasutti, & Croft, 2009; Marlowe, Festinger, Dugosh, Lee, & Benasutti, 2007; Marlowe, Festinger, Lee, Dugosh, & Benasutti, 2006; Marlowe et al., 2003; Rossman, Roman, Zweig, Rempel, & Lindquist, 2011; Satel, 1998) .
Despite substantial support for judicial status hearings as a key component of drug court, little is known about how well drug court clients are able to fully understand the reasons for certain judicial responses and make clear connections between their behaviors and the resulting consequences. For example, although judges generally refer to specific dates of drug use, it may be difficult for clients to effectively process the information or to understand longitudinal patterns of behavior. This may leave drug court clients confused about what happened during their hearings. Such confusion may cause clients to misunderstand what is expected of them, and/or to feel mistreated and interpret the judge's actions as arbitrary, meanspirited, or prejudicial, resulting in reduced perceptions of fairness and procedural justice. These feelings may diminish the effectiveness of the program, as evidence from decision theory suggests that individuals are less likely to abide by judicial decisions that they believe to be unfair (Sydeman, Cascardi, Poythress, & Ritterband, 1997; Tyler, 1992) . However, judges may not have the tools to adequately communicate to clients. Fortunately, as discussed below, research suggests that the use of visual aids may be an effective strategy to improve communication and understanding among individuals who have substance use disorders (e.g., Czuchry, Dansereau, Dees, & Simpson, 1995; Dansereau, Joe, & Simpson, 1995; Miller, Benefield, & Tonigan, 1993) .
Improving Communication Through Visual Aids
One potentially promising strategy for improving communication between the judge and drug court clients is the use of visual aids during status hearings. Visual aids and graphic information can significantly improve the transfer and understanding of information. Furthermore, they may serve to enhance clients' perceptions of fairness and increase the effectiveness of the program. Research has demonstrated that visual diagrams are superior to verbal explanations for learning and retention of complex information (Glenberg & Langston, 1992; Mayer & Gallini, 1990) and that two-dimensional visual representations (e.g., Venn diagrams, flowcharts, graphs) are generally more computationally efficient than natural language, whether spoken or written (Larkin & Simon, 1987; Mayer & Gallini, 1990) . This is particularly true of simple line-graphs that depict the relationship between only two variables or changes in one variable over time (Larkin & Simon, 1987; Mayer & Gallini, 1990) . Studies have also demonstrated that understanding and memory are enhanced when a graph is converted from bars or histograms to lines, when multiple dependent variables are split up into separate graphs, and when the scale of the dependent measure reflects percentages or temporal intervals (e.g., weeks, months) rather than absolute scores (Shah, Mayer, & Hegarty, 1999) . Graphs that are organized in a way that supports pattern recognition (e.g., weekly drug use) are easier to interpret than those requiring logical inferences such as "chunking" assessment intervals into weeks (Shah & Carpenter, 1995) .
Research supports the use of graphic visual-feedback in improving understanding and outcomes for individuals who have substance use disorders. For example, Miller's Drinker's Check-Up (e.g., Miller et al., 1993) , a core technique employed in motivational enhancement therapy, requires clinicians to provide graphic feedback related to behavioral and biological metrics for their alcohol use. In this technique, the client's objective data is displayed in graphic form along with normative data for comparison purposes. The Drinker's Check-Up has been shown to reduce alcohol use among problem drinkers (Bein, Miller, & Boroughs, This document is copyrighted by the American Psychological Association or one of its allied publishers.
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1993; J. M. Brown & Miller, 1993; Miller et al., 1993; Handmaker, Miller, & Manicke, 1999 ) and similar approaches have been shown to be effective in reducing cannabis use (Stephens, Roffman, Fearer, Williams, & Burke, 2007) . Similarly, node-link mapping in which clients' ideas or behaviors are visually represented in schematic or graphic form has been shown to help clients maintain focused attention during treatment sessions and improve drug use outcomes (Czuchry et al., 1995; Dansereau et al., 1995) .
Moreover, it appears to reduce cultural, racial, and class communication barriers by providing a visual supplement and common language that enhances counselor-client exchanges (Dansereau, Joe, Dees, & Simpson, 1996) .
Examining Visual Performance Feedback in Drug Court
To date, visual aids have not been examined as a means of improving communication between drug court judges and clients during judicial status hearings. Given the critical role that status hearings play in drug court clients' success, it is reasonable to hypothesize that providing graphic performance feedback during status hearings can serve to improve judicial communication linking specific behaviors and their consequences, thereby increasing the effectiveness of behavioral modification, the perceived fairness of judicial actions, and richness of the interactions between the judge and client. Such a procedure may be particularly useful in this context as drug courts serve a disproportionate number of individuals with lower socioeconomic means and educational achievement, lower levels of attention, and higher levels of situational stress.
The current two-group randomized pilot study examined the feasibility, acceptability, and preliminary efficacy of using visual performance feedback (VPF) during drug court status hearings. Specifically, drug court clients' weekly urine analysis results and treatment attendance were projected onto the courtroom wall and verbally presented by the judge. We hypothesized that the judicial status hearings supplemented with visual performance feedback would (a) be feasible to implement in the context of regularly scheduled judicial status hearings, (b) be viewed as acceptable to stakeholders and clients, (c) result in improved drug court outcomes including reduced drug use and increased treatment attendance, (d) increase the duration of judge-client interactions compared with judicial status hearings without VPF, and (e) lead to increased perceptions of fairness in the judicial process (i.e., procedural justice).
Method
The study was approved and overseen by the Institutional Review Boards (IRBs) of the Treatment Research Institute and the Delaware Department of Health and Human Services.
Participants and Setting
Participants were recruited from a misdemeanor drug court located in a northeast metropolitan city. To be eligible for enrollment in the drug court, defendants had to (a) be at least 18 years of age; (b) be a resident of or have committed their offense in New Castle County, DE; (c) be charged with a misdemeanor drug offense including possession or consumption of cannabis, possession of drug paraphernalia, or possession of hypodermic syringes; and (e) not have a history of a violent offense involving serious injury to a victim or the use of a deadly weapon. Defendants are required to plead guilty to the initial charge(s) and the guilty plea is held in abeyance pending graduation or termination from the program. Drug court graduates have their plea and charges withdrawn upon program completion and are eligible to have the arrest record expunged if they remain arrest-free for an additional 6 months. If the defendant fails to complete the program, the guilty plea is formally entered as a conviction.
The program is designed to be a minimum of 18 weeks in length and there is no maximum time limit for enrollment. To graduate from the program, participants must attend at least 12 weekly psycho-educational group classes, provide 14 consecutive weeks of drug-negative urine specimens, remain arrest-free, obey the program's rules and procedures, and pay a $200 court fee. Participants provided weekly random drug specimens that were tested by an independent certified laboratory using the enzyme multiplied immunoassay technique (EMIT) with gas chromatography/mass spectrometry (GCMS) confirmation of positive results. The urine specimens were tested for cannabis, alcohol, opiates, amphetamines, cocaine, and phencyclidine (PCP), plus any additional substances that were believed to be abused by the individual. All defendants who were scheduled to attend a drug court orientation (i.e., colloquy) between November 11, 2012, and February 6, 2014, were informed about the study by research staff prior to the orientation meeting and formal drug court entry (N ϭ 137). Research staff provided them with a brief, oral description of the study that included participation requirements, payment incentives, confidentiality protections, and the right to refuse or withdraw from the study at any time. At the time of orientation, a total of 31 individuals were deemed ineligible for the drug court program and, consequently, the study because they resided outside of the county, and an additional 31 participants refused to participate. Interested clients were then taken through an individualized informed consent procedure. Consenting clients (N ϭ 75; 71% of those eligible) were randomized in approximately equal proportions to the VPF (n ϭ 37) and status hearing as usual (AU; n ϭ 38) conditions. It is important to note that the judge in this court held both morning and afternoon hearings and agreed to allow the investigators to randomly assign VPF clients to the afternoon hearings and AU clients to the morning sessions. This allowed investigators to keep the treatment conditions separate, improving the logistical procedures and reducing the potential for client contrast effects. Individuals who consented to participate and those who refused did not differ significantly in age (p ϭ .11), gender (p ϭ .13), type of counsel (p ϭ .82), or type of charge (p ϭ .63).
Participants were predominantly male (n ϭ 63; 84%) with an average age of 21.60 years (SD ϭ 3.97). A total of 72% of the sample was Caucasian (n ϭ 54) and 25% was African American (n ϭ 19). Approximately 12% (n ϭ 9) of the sample was Hispanic. The majority of participants were never married (n ϭ 73; 97%) and not employed full-time (n ϭ 45; 60%). The most frequently reported substances of abuse were marijuana (n ϭ 71; 95%), alcohol (n ϭ 47; 63%), hallucinogens (n ϭ 9; 12%), amphetamines (n ϭ 6; 8%), cocaine (n ϭ 4; 5%), other opiates (n ϭ 4; 5%), sedatives (n ϭ 3; 4%), and heroin (n ϭ 2; 3%). The large majority of participants had no history of substance abuse treatThis document is copyrighted by the American Psychological Association or one of its allied publishers.
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Procedures
Drug court clients were required to attend monthly status hearings in which their progress including urine drug screen results and treatment attendance was discussed openly in front of other members of the gallery (i.e., court observers). Prior to each hearing, the judge received information about each client's progress including urinalysis results and treatment attendance that was generated through the TRI-Court Evaluation Program (TRI-CEP), a state-ofthe-art information management system that gathers information about client progress from key stakeholders (Treatment Research Institute, 2016) . Treatment program staff was responsible for entering data regarding urinalysis results and treatment attendance into the TRI-CEP system. The TRI-CEP system, for the purposes of the current study, has a graphing feature that generated individual two-dimensional line graphs of (a) weekly urinalysis results and (b) treatment attendance results. It is important to note that these types of graphs can be easily created using any type of graphing program and do not require the use of the TRI-CEP system.
Participants who were assigned to the AU condition received verbal performance reports from the judge as usual and those who were assigned to the VPF condition received visual performance feedback from the judge during their first four monthly postentry status hearings. Participants in the VPF condition attended afternoon status hearings beginning at 1:00 p.m., whereas participants in the AU condition attended morning status hearings starting at 10:00 a.m. For clients in the VPF condition, the judge presented two graphs for each client, one depicting weekly abstinence and one depicting weekly treatment attendance for the past 8 weeks. The graphs were projected onto a large screen in the courtroom in plain view of the client, program staff, and observers. The judge followed a scripted outline (described below) to convey the information depicted in the graphs and used a laser pointer to help orient clients to the graphs and to describe their progress.
Prior to implementing the VPF procedure, the study investigators held three 30 min training sessions with the judge. The sessions primarily focused on training the judge on delivery of the VPF procedures and how to orient participants to the graphs using a laser pointer. It is important to note that these trainings did not attempt to influence the judge's personal style of interacting with drug court participants. The flow for the VPF procedure was as follows: This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
3. The judge then reviewed their current results, discussed other patterns in outcome data, and made other points as necessary.
4. This process was then repeated for the past 8 weeks of treatment attendance.
Client Assessments and Outcomes
After providing written informed consent, all participants completed a 10-min baseline assessment battery that included a detailed locator form to provide contact information and a demographic questionnaire. Participants completed a 15-min follow-up assessment to measure procedural justice and acceptability of the VPF procedure following their Month 4 status hearing (n ϭ 39; VPF n ϭ 20, AU n ϭ 19) or following their final status hearing if they were graduated or terminated prior to that time [(Month 1: n ϭ 1; VPF n ϭ 1, AU n ϭ 0); (Month 2: n ϭ 18; VPF n ϭ 9, AU n ϭ 9); Month 3: n ϭ 17; VPF n ϭ 7, AU n ϭ 10)]. In the VPF condition, 1 participant was terminated at week 1 and 2 participants were terminated at week 2. No participants were terminated in the AU condition. The remainder of participants were active or had graduated at the time of the final assessment. Participants received $25 for completing each assessment.
The primary preliminary efficacy outcomes were urinalysisconfirmed abstinence and treatment attendance. As discussed above, treatment program staff entered this information into the TRI-CEP system on a weekly basis. Urine drug testing was performed by an independent certified laboratory using EMIT with GCMS confirmation and results were entered into the TRI-CEP system. Samples were routinely tested for cannabis, cocaine, opiates, PCP, and amphetamines. For each client, (a) the percentage of scheduled drug-free urines provided and (b) the percentage of scheduled treatment sessions attended during weeks 1-16 were calculated. Because the treatment attendance variable was extremely skewed, the variable was dichotomized to reflect whether or not the participant attended all scheduled treatment sessions. In addition, procedural justice was measured at the follow-up assessment using Tyler's (1994) Legal Authority Questions (LAQ; Tyler, 1994) . Procedural justice relates to clients' understanding of how the court reached their decisions as well as their beliefs that fair procedures were employed by the court in making these decisions. Nine items comprise the LAQ, and the items reflect the neutrality, trustworthiness, and standing dimensions of procedural justice. Specific items measure how individuals perceive themselves as being treated by authorities in terms of politeness, respect, and dignity, beliefs about the benevolent or malevolent intentions of authorities, and lack of bias by authorities. Participants rate their agreement with each item on a 5-point Likert scale (1 ϭ strongly disagree; 5 ϭ strongly agree). Scores were calculated by averaging participant responses to the 9 items. Finally, acceptability of the VPF procedure to participants who received it was evaluated at the follow-up assessment using a 6-item Likertscaled Performance Monitoring Questionnaire.
Stakeholder Assessments
Key drug court stakeholders (e.g., judge, court coordinator, treatment providers, case managers, attorneys) completed a brief questionnaire to evaluate their perceptions of the VPF procedure at the end of the study. The questionnaire contained 8 Likert-scaled items measuring ease of use, utility, and efficacy of the VPF intervention. Stakeholders rated their agreement with each item on a 5-point Likert scale (1 ϭ strongly disagree; 5 ϭ strongly agree). The questionnaire was anonymous and included no unique identifiers.
Observational Process Data
A research assistant was in attendance at each status hearing. They rated judge fidelity to the VPF procedure as a measure of feasibility. The checklist contained the following six items pertaining to the judge's behavior: (a) drew client's attention to the graphs, (b) explained that the x-axis represents specific weeks in the program, (c) explained what the red and green symbols mean, (e) explained that the higher the line goes, the better the client's progress, (e) explained that the dashed green line indicates perfect performance, and (f) interpreted client's progress as indicated in the graphs. At each client status hearing, the research assistant indicated a 0 if the behavior did not occur and a 1 if the behavior did occur. Ratings were recorded for each type of graph (i.e., urinalysis result, treatment attendance). Summary scores were calculated for each type of graph by counting the number of behaviors that occurred and dividing that number by 6 (i.e., the number of targeted behaviors). Thus, each type of summary score (i.e., urinalysis result, treatment attendance) reflected the percentage of targeted behaviors that occurred and could range from 0 (judge exhibited none of the targeted behaviors) to 1 (judge exhibited all of the targeted behaviors).
In addition, each judge-client interaction was timed to compare the number of minutes spent with each client in the two groups. For each client, the number of minutes spent with the judge was averaged across status hearings. The average duration of the interaction served as an outcome to be compared between the two groups.
Data Analysis
Descriptive statistics were calculated for client and stakeholder acceptability and feasibility (i.e., fidelity) items. T tests were used to compare VPF and AU clients on the proportion of drug-negative urines provided during the study period (i.e., weeks 1-18; unexcused missing data were imputed as positive), the average duration (minutes) of the judge-client interactions, procedural justice scores at the final assessment, and working alliance at the final assessment. The proportion of participants completing all treatment sessions was compared between the two groups using a chi-square test.
Results

Feasibility of Procedures
As discussed, feasibility of the VPF procedure was evaluated by determining the extent to which the judge presented the urinalysis and treatment attendance graphs with fidelity as measured by observer ratings on the fidelity checklist. 
Acceptability to Clients
All clients in the VPF condition completed the Performance Monitoring Questionnaire following their final status hearing. All participants indicated that the slides were easy to understand [30 participants (81%) strongly agreed and 7 (19%) agreed with the corresponding statement]. Participants felt the slide presentation generally helped them somewhat (n ϭ 12; 32%) or a great deal (n ϭ 25; 68%). They felt that the slides helped them to understand their progress in the drug court program somewhat (n ϭ 3, 8%) or a great deal (n ϭ 34; 92%). The large majority of participants indicated that the slide presentation was better (n ϭ 19; 51%) or much better (n ϭ 17; 46%) than how the judge typically reviews client progress and that they would probably (n ϭ 12; 32%) or definitely (n ϭ 24; 65%) like to have their progress reviewed using the slide format in the future. Only one participant indicated that the procedure was worse than the usual format and that they would probably not like to have their progress reviewed in this way in the future.
Acceptability to Stakeholders
A total of 10 stakeholders (i.e., 1 judge, 1 public defender, 5 court staff, 3 treatment providers) completed the acceptability survey. As seen in Table 2 , they generally had very positive perceptions about the use of the VPF procedure. All stakeholders agreed (n ϭ 8; 80%) or strongly agreed (n ϭ 2; 20%) that visual feedback slides were clear and easy for clients to understand. The large majority of stakeholders agreed (n ϭ 3; 30%) or strongly agreed (n ϭ 4; 40%) that the VPF procedure was easy to facilitate. Eighty percent of the sample disagreed (n ϭ 5; 50%) or strongly disagreed (n ϭ 3; 30%) that the VPF procedure got in the way of standard operations. A similar proportion of stakeholders agreed (n ϭ 5; 50%) or strongly agreed (n ϭ 3; 30%), disagreed (n ϭ 5; 50%) or strongly disagreed (n ϭ 3; 30%) that the VPF procedure was useful for the court, and all disagreed (n ϭ 8; 80%) or strongly disagreed (n ϭ 3; 20%) that it was problematic. Seventy percent agreed (n ϭ 6; 60%) or strongly disagreed (n ϭ 1; 10%) that the procedure would improve client outcomes and 80% agreed (n ϭ 7; 70%) or strongly agreed (n ϭ 1; 10%) that the VPF would be a great addition to their court. Finally, 60% agreed (n ϭ 5; 50%) or strongly agreed (n ϭ 1; 10%) that the procedure was likely to be used by other courts. Overall, stakeholders indicated no negative perceptions of the VPF procedure following its implementation in the court.
Preliminary Efficacy
Urinalysis-confirmed abstinence. The two groups were compared on the proportion of drug-negative urine screens provided during the study period. As discussed above, nonexcused failures to provide a urinalysis sample were treated as drugpositive. Participants in the two groups provided a similar percentage of drug-negative urine specimens (VPF: M ϭ 0.67, SD ϭ 0.32; AU: M ϭ 0.69, SD ϭ 0.30; t(73) ϭ 0.26, p ϭ .80, d ϭ 0.06). Similar results were observed when nonexcused failures to provide a urinalysis sample were treated as missing data.
Treatment attendance. The proportion of participants who attended all scheduled treatment sessions during the study period was compared for the two groups. Sixty-two percent (n ϭ 23) of VPF participants completed all scheduled sessions compared with 66% (n ϭ 25) of those in the AU condition. This difference was not statistically significant, 2 ϭ 0.11, p ϭ .74, ϭ .04. This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Duration of judge-client interactions. The two groups were compared on the average duration (in minutes) of the judge-client interaction during status hearings. Results indicated that the average duration of the judge-client interaction was higher in the VPF condition (M ϭ 3.27, SD ϭ 1.52; range ϭ 1.3-7.25) than in the AU condition (M ϭ 2.55, SD ϭ 0.94; range ϭ 1.0 -5.33). This difference reached statistical significance, t (73) 
Discussion
Results indicated the VPF procedure was a feasible and acceptable way to present information about client performance during drug court status hearings. Overall, the judge generally followed VPF procedures in presenting urinalysis results (81%-91% adherence on average) and treatment attendance (79%-91% adherence on average). Furthermore, the procedure was acceptable to drug court stakeholders and clients. The majority of stakeholders reported very favorable perceptions of the procedure and noted no negative perceptions. Similarly, clients reported that the slides were helpful and that they helped them understand their progress in the program. The large majority indicated that the VPF was better than the usual procedures and that they would like having their progress displayed in this way in the future; only one participant reported concerns about the use of the VPF procedure. In sum, this study demonstrated the feasibility and acceptability of using VPF in drug courts.
Results for the preliminary efficacy hypotheses were less definitive. Participants in the two groups displayed similar performance in terms of urinalysis-confirmed abstinence rates and treatment session attendance. Additionally, procedural justice scores were similar between the two groups. However, for treatment session attendance and procedural justice in particular, results may reflect a ceiling effect. Almost two thirds of clients attended all of their scheduled treatment sessions. Similarly, procedural justice scores were high overall, with averages at the last anchor of the scale in both groups. It is important to note that one significant efficacy finding did emerge; status hearings were significantly longer in duration within the VPF condition than the AU condition (3.27 vs. 2.55 min, respectively). As discussed earlier, research indicates that better drug court outcomes are observed when interactions between the judge and clients are greater than 3 min (Carey et al., 2008; Carey, Mackin, & Finigan, 2012) . Although the VPF procedure did not appear to directly influence other outcomes in this pilot study and may merely have been an artifact of the additional time taken by the judge to review the graphs, it did extend the duration of the judge-client interactions and might be found to impact outcomes in future, more fully powered efficacy trials.
This pilot study has several limitations. First, it was conducted in a single urban misdemeanor drug court that has a history of participating in research with our group. As such, the generalizability of the findings to other courts and types of courts (e.g., felony, rural, research-naive) is unknown. Second, the study is a pilot trial with a very limited sample size. Because the primary purpose of this pilot study was to examine feasibility and acceptability of the VPF procedure, it was not fully powered to detect differences on the efficacy outcomes. In addition, the sample size precluded the examination of potential moderators of the intervention including substance use disorder severity, level of criminogenic risk, and cognitive function. Prior studies have demonstrated significant interaction effects between client factors and drug court procedures on outcomes. For example, Festinger et al. (2002) found that drug court clients with prior treatment failures or who met diagnostic criteria for antisocial personality disorder achieved better outcomes when scheduled to more frequent status hearings, and clients who did not meet these criteria did better with less frequent hearings. Third, although typical of research in criminal justice settings, nearly 30% of individuals approached about the study chose not to participate. This raises the possibility of systematic differences between participants and nonparticipants that we did not measure that may affect the generalizability of the findings. For instance, individuals who chose to join the study may have been more motivated and/or more likely to be compliant than those who did not. Finally, although participants ranked their perception about the ease of use and increased understanding in the VPF condition, there were no objective measures used to determine whether or not understanding was in fact increased.
Although prior research has indicated that the use of visual feedback can improve outcomes in behavior modification protocols for individuals who have substance use disorders in procedures such as the Drinker's (e.g., Bein et al., 1993; J. M. Brown & This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. Miller et al., 1993) and Cannabis User's (Stephens et al., 2007) Check-ups, this is the first trial to experimentally evaluate the feasibility of using multiple feedback modalities (visual and verbal) to improve outcomes and promote behavior change in clients with substance use histories attending drug court. It has been postulated (Larkin & Simon, 1987; Winn, 1991) that visual feedback may be more computationally efficient and require less cognitive effort than verbal feedback. Overall, this study demonstrated the feasibility and acceptability of providing visual performance feedback to drug court clients during judicial status hearings. Unfortunately, clear evidence supporting its efficacy in improving client outcomes was not obtained. It is possible that the VPF may be more effective in drug courts that serve individuals with more severe substance use disorders and criminal histories. The large majority of the sample in both conditions were completely compliant with their treatment requirements and many graduated following their second status hearing. This may have led to a ceiling effect which may have reduced the utility of feedback and our ability to detect the effects of the intervention. Future fully powered trials of the VPF procedure are needed to further examine its efficacy in improving outcomes in a more diverse population of drug court clients.
